Free Trial

LGT Fund Management Co Ltd. Makes New Investment in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background
Remove Ads

LGT Fund Management Co Ltd. purchased a new position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 37,265 shares of the company's stock, valued at approximately $2,391,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. State Street Corp raised its position in Ryan Specialty by 1.5% in the 3rd quarter. State Street Corp now owns 3,273,093 shares of the company's stock valued at $217,301,000 after purchasing an additional 49,198 shares during the last quarter. Janus Henderson Group PLC increased its position in Ryan Specialty by 0.4% in the 3rd quarter. Janus Henderson Group PLC now owns 3,148,916 shares of the company's stock valued at $209,058,000 after acquiring an additional 13,986 shares during the period. Principal Financial Group Inc. lifted its position in Ryan Specialty by 115.2% during the 4th quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock worth $117,619,000 after acquiring an additional 981,505 shares during the period. Barclays PLC grew its stake in shares of Ryan Specialty by 1.1% in the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company's stock valued at $108,994,000 after purchasing an additional 17,267 shares during the last quarter. Finally, Eagle Asset Management Inc. increased its holdings in shares of Ryan Specialty by 32.1% in the third quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company's stock valued at $98,555,000 after purchasing an additional 335,180 shares during the period. Hedge funds and other institutional investors own 84.82% of the company's stock.

Remove Ads

Insider Buying and Selling

In related news, Director Nicholas Dominic Cortezi sold 35,000 shares of the company's stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $66.71, for a total transaction of $2,334,850.00. Following the transaction, the director now owns 60,200 shares of the company's stock, valued at approximately $4,015,942. This represents a 36.76 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In the last quarter, insiders sold 316,451 shares of company stock worth $20,907,793. 11.10% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages have commented on RYAN. UBS Group upped their price objective on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Keefe, Bruyette & Woods reduced their price objective on shares of Ryan Specialty from $77.00 to $76.00 and set an "outperform" rating for the company in a research report on Friday, February 21st. Morgan Stanley started coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 price objective on the stock. Royal Bank of Canada reduced their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a report on Friday, February 21st. Finally, Barclays increased their price objective on Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a research report on Thursday, November 21st. One research analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat.com, Ryan Specialty presently has an average rating of "Hold" and a consensus price target of $75.27.

Check Out Our Latest Stock Analysis on Ryan Specialty

Ryan Specialty Price Performance

NYSE:RYAN traded down $1.46 during mid-day trading on Thursday, hitting $69.26. 884,592 shares of the company's stock traded hands, compared to its average volume of 993,786. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market cap of $18.14 billion, a PE ratio of 100.38, a price-to-earnings-growth ratio of 1.19 and a beta of 0.72. The firm's 50 day simple moving average is $66.36 and its 200 day simple moving average is $67.53. Ryan Specialty Holdings, Inc. has a 1 year low of $48.48 and a 1 year high of $75.97.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The business had revenue of $663.53 million for the quarter, compared to analysts' expectations of $658.80 million. Sell-side analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th will be given a $0.12 dividend. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. This represents a $0.48 annualized dividend and a dividend yield of 0.69%. The ex-dividend date is Tuesday, March 4th. Ryan Specialty's dividend payout ratio is currently 69.57%.

Ryan Specialty Profile

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Recommended Stories

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads